# Onset and Duration of Mometasone by Oscillometry and Spirometry

> **NCT01635088** · PHASE4 · COMPLETED · sponsor: **California Allergy and Asthma Medical Group, Inc.** · enrollment: 21 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Mometasone furoate 220
- **DEVICE:** KoKo Spirometry
- **DRUG:** Mometasone furoate 440
- **DEVICE:** Oscillometry

## Key facts

- **NCT ID:** NCT01635088
- **Lead sponsor:** California Allergy and Asthma Medical Group, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-12
- **Final completion:** —
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2013-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01635088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01635088, "Onset and Duration of Mometasone by Oscillometry and Spirometry". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01635088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*